Monoamine Oxidase-Related Vascular Oxidative Stress in Diseases Associated with Inflammatory Burden

Area of Science:

• Biochemistry
• Molecular Biology
• Pathology

Background:

• Monoamine oxidases (MAO), with isoforms A and B, are crucial mitochondrial flavoenzymes involved in neurotransmitter and biogenic amine metabolism.
• MAO activity generates by-products like aldehydes and hydrogen peroxide, contributing to oxidative stress.
• Emerging evidence links MAO-derived oxidative stress to cardiovascular and metabolic diseases, alongside chronic inflammation.

Purpose of the Study:

• To review the role of MAO in vascular oxidative stress and endothelial dysfunction.
• To summarize MAO's contribution to hypertension, metabolic disorders, and chronic kidney disease.
• To highlight MAO inhibition as a therapeutic strategy for these inflammatory conditions.

Main Methods:

• Literature review of studies on MAO function and its role in disease.
• Analysis of research on oxidative stress and inflammation in cardiovascular and metabolic pathologies.
• Evaluation of evidence for MAO inhibitors in preclinical and clinical settings.

Main Results:

• MAO contributes significantly to vascular oxidative stress and endothelial dysfunction.
• MAO activity is implicated in the pathogenesis of hypertension, metabolic disorders, and chronic kidney disease.
• Newer, selective MAO inhibitors show promise in mitigating oxidative stress and inflammation.

Conclusions:

• MAO plays a key role in the oxidative stress underlying major noncommunicable diseases.
• Targeting MAO with selective inhibitors is a promising therapeutic approach.
• Further research into MAO inhibition could lead to novel treatments for cardiovascular and metabolic diseases.